I am a breastfeeding mother and i want to know if it is safe to use 1,7,7-Trimethylnorcamphor? Is 1,7,7-Trimethylnorcamphor safe for nursing mother and child? Does 1,7,7-Trimethylnorcamphor extracts into breast milk? Does 1,7,7-Trimethylnorcamphor has any long term or short term side effects on infants? Can 1,7,7-Trimethylnorcamphor influence milk supply or can 1,7,7-Trimethylnorcamphor decrease milk supply in lactating mothers?
- DrLact safety Score for 1,7,7-Trimethylnorcamphor is 5 out of 8 which is considered Unsafe as per our analyses.
- A safety Score of 5 indicates that usage of 1,7,7-Trimethylnorcamphor may cause serious side effects in breastfed baby.
- Our study of different scientific research indicates that 1,7,7-Trimethylnorcamphor may cause moderate to high side effects or may affect milk supply in lactating mother.
- Our suggestion is to use safer alternate options rather than using 1,7,7-Trimethylnorcamphor .
- It is recommended to evaluate the advantage of not breastfeeding while using 1,7,7-Trimethylnorcamphor Vs not using 1,7,7-Trimethylnorcamphor And continue breastfeeding.
- While using 1,7,7-Trimethylnorcamphor Its must to monitor child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Substance which can be extracted under distillation from the 1,7,7-Trimethylnorcamphor tree bark. Nowadays it is synthesized from the Turpentine. Used with creams and lotions as local anti-inflammatory agent. There is no proof of effectiveness as decongestant or expectorant when used in inhaled preparations, but as a toxic agent. 1,7,7-Trimethylnorcamphor is a highly lipophilic substance which is well absorbed by whatever via of administration (skin, inhalation, mouth) that crosses easily the cell membrane. Pharmacokinetic data support the likelihood of excretion into breast milk in a significant amount. 1,7,7-Trimethylnorcamphor has been shown to be toxic at low dose on infants in whom it may cause headache, vomiting, seizures and coma. It should never be administered by mouth. It is not appropriate its use during breastfeeding, and, in whatever case, it should not be applied on the mother's breast, since severe intoxications be occurred in infants after use of small ingested amounts. Be aware of not using it in the nostrils.
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.